Related Experiment Video
Updated: Jan 22, 2026
Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
Published on: August 30, 2024
Association Between Postoperative Dexmedetomidine Use and Arrhythmias in Infants After Cardiac Surgery
Laura A Ortmann1, Meera Keshary2, Karl Stessy Bisselou3
11 Department of Pediatrics, Division of Critical Care, Children's Hospital and Medical Center, Omaha, NE, USA.
Insights
Dexmedetomidine may reduce tachyarrhythmias in high-risk infants after congenital heart surgery. However, this protective effect was not statistically significant after adjusting for patient differences, indicating further research is needed for arrhythmia prophylaxis.
Area of Science:
- Pediatric Cardiology
- Cardiac Surgery
- Pharmacology
Background:
- Dexmedetomidine is explored for arrhythmia prevention post-congenital heart surgery due to its heart rate-lowering properties.
- Conflicting evidence exists regarding its efficacy, necessitating further investigation, especially in high-risk infant populations.
Purpose of the Study:
- To evaluate the effectiveness of dexmedetomidine in preventing arrhythmias in high-risk infants undergoing surgery for congenital heart disease.
- To compare arrhythmia incidence in infants receiving dexmedetomidine for sedation versus those who did not.
Main Methods:
- Retrospective cohort study involving infants under six months old who underwent cardiopulmonary bypass for congenital heart disease.
- Comparison of arrhythmia incidence within 48 hours post-surgery between infants who received dexmedetomidine and those who did not.
Main Results:
- No significant difference in tachyarrhythmia incidence between the dexmedetomidine (15%) and non-dexmedetomidine (19%) groups.
- The non-dexmedetomidine group showed a higher need for arrhythmia treatment (18% vs. 8%).
- Infants with high-risk lesions (tetralogy of Fallot, transposition of great arteries, AV canal) had higher tachyarrhythmia rates without dexmedetomidine (34% vs. 6%).
Conclusions:
- Dexmedetomidine administration was associated with a trend towards decreased tachyarrhythmias in high-risk infants.
- This observed benefit did not reach statistical significance after adjusting for baseline patient characteristics.
- Further studies are warranted to clarify the role of dexmedetomidine in postoperative arrhythmia management.
Background:
Dexmedetomidine has been suggested as an arrhythmia prophylactic agent after surgery for congenital heart disease due to its heart rate lowering effect, though studies are conflicting. We sought to study the effect of dexmedetomidine in infants that are at highest risk for arrhythmias.
Methods:
Retrospective cohort study of infants less than six months of age undergoing cardiopulmonary bypass for congenital heart disease. The arrhythmia incidence in the first 48 hours after surgery in infants receiving dexmedetomidine for sedation was compared to those that did not receive dexmedetomidine.
Results:
A total of 309 patients were included, 206 patients who did not receive dexmedetomidine and 103 patients who did. The incidence of tachyarrhythmias was similar between the non-DEX group and the DEX group (19% vs 15%, P = .34). When adjusted for baseline differences, the non-DEX group did not have an increased risk of postoperative tachyarrhythmias (odds ratio [OR]: 1.4, 95% confidence interval [CI]: 0.5-3.8). The non-DEX group had an increased need for treatment for arrhythmias (18% vs 8%, P = .012). The three lesions with baseline higher risk for arrhythmias (tetralogy of Fallot, transposition of the great arteries, and complete atrioventricular canal) had an increased incidence of tachyarrhythmias in the non-DEX group (34% vs 6%, P = .027). This risk was not significant in multivariate analysis (OR: 2.5, 95% CI: 0.4-15.5).
Conclusions:
High-risk infants had decreased incidence of tachyarrhythmias when receiving dexmedetomidine, though this was not significant after accounting for baseline differences between groups.
More Related Videos
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
05:15Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk
Published on: July 27, 2022
Related Concept Videos
01:28Mechanism of Cardiac Arrhythmias
01:16ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
01:21Association Areas of the Cortex
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
01:27Associative Learning
Classical conditioning, also known...
01:29Drug Dosing: Infants and Children